Last $52.53 USD
Change Today +0.50 / 0.96%
Volume 62.2K
HELE On Other Exchanges
Symbol
Exchange
Munich
NASDAQ GS
As of 11:15 AM 10/2/14 All times are local (Market data is delayed by at least 15 minutes).

helen of troy ltd (HELE) Key Developments

Helen of Troy Limited Revises Earnings Guidance for the Second Quarter and Full Fiscal Year of 2015

Helen of Troy Limited revised earnings guidance for the second quarter and full fiscal year of 2015. For second quarter, the company expects net sales revenue excluding Healthy Directions in the range of $291 to $294 million, and diluted EPS (GAAP) in the range of $0.58 to $0.61. Projected sales from the Healthy Directions acquisition is expected to be in the range of $22 million to $24 million. Healthy Directions' diluted EPS (GAAP) is expected to be in the range of $(0.02) to $0.00, which includes acquisition-related expenses of $0.08 per share, net of tax. Healthy Directions' diluted EPS excluding acquisition-related expenses (non-GAAP), is expected to be in the range of $0.06 to $0.08 for the quarter ended August 31, 2014. Including Healthy Directions, consolidated diluted EPS without significant items (non-GAAP) is expected to be in the range of $0.64 to $0.69 for the quarter ended August 31, 2014. Cash EPS (non-GAAP) excluding Healthy Directions is being introduced in the range of $0.79 to $0.82, which excludes intangible asset amortization expense and non-cash share-based compensation expense. Consolidated cash EPS (non-GAAP) including Healthy Directions is being introduced in the range of $0.87 to $0.92. For the fiscal year 2015, the company expects sales revenue, excluding its Healthy Directions, in the range of $1.275 to $1.30 billion and GAAP EPS of $3.42 to $3.52 per share. Excluding charges, non-GAAP EPS is seen at $3.70 to $3.80 per share, below its prior outlook of $4.30 to $4.40 per share. Projected sales and diluted EPS (GAAP) from the Healthy Directions acquisition is expected to be in the range of $100 million to $105 million and $0.12 to $0.16, respectively, for the remaining eight months of the fiscal year since acquisition. Healthy Directions diluted EPS without significant items (non-GAAP), which excludes acquisition-related expenses of $0.08 per share, is expected to be in the range of $0.20 to $0.24. The company now expects consolidated net sales revenue including Healthy Directions in the range of $1.375 to $1.405 billion. Including Healthy Directions, consolidated diluted EPS excluding significant items (non-GAAP) is now expected to be in the range of $3.90 to $4.04. Cash EPS excluding Healthy Directions is now expected to be in the range of $4.55 to $4.65, which excludes after-tax non-cash asset impairment charges, intangible asset amortization expense, and non-cash share-based compensation expense. This compares to the prior Cash EPS outlook in the range of $5.15 to $5.25, which did not include any impact of the Healthy Directions acquisition. Consolidated cash EPS including Healthy Directions is expected to be in the range of $4.87 to $5.01.

Helen of Troy Limited, 2015 Guidance/Update Call, Sep 02, 2014

Helen of Troy Limited, 2015 Guidance/Update Call, Sep 02, 2014

Helen of Troy Limited Presents at Barclays Capital Back-to-School Consumer Conference 2014, Sep-03-2014 08:15 AM

Helen of Troy Limited Presents at Barclays Capital Back-to-School Consumer Conference 2014, Sep-03-2014 08:15 AM. Venue: InterContinental Hotel, Boston, Massachusetts, United States. Speakers: Brian L. Grass, Chief Financial Officer, Julien R. Mininberg, Chief Executive Officer and Director.

Helen of Troy Limited Reports Unaudited Consolidated Earnings Results for the First Quarter Ended May 31, 2014; Reports Non-Cash Asset Impairment Charges for the First Quarter Ended May 31, 2014; Provides Earnings Guidance for the Nine Months and Fiscal Year Ending February 28, 2015

Helen of Troy Limited reported unaudited consolidated earnings results for the first quarter ended May 31, 2014. For the quarter, the company’s net sales revenue grew to a record $311.778 million compared to $304.516 million in the first quarter of fiscal year 2014. Operating income was $23.123 million, and includes $9.0 million in non-cash asset impairment charges related to certain trademarks in the company's personal care segment. This is compared to operating income of $20.626 million in the same period last year, which includes the impact of $12.0 million in non--cash asset impairment charges related to certain trademarks in the company's personal care segment. Income before income taxes was $19.756 million against $17.768 million a year ago. Net income was $16.398 million or $0.55 per diluted share against $14.392 million or $0.45 per diluted share a year ago. Non-GAAP operating income was $32.123 million against $32.675 million a year ago. Non-GAAP income before income taxes was $28.756 million against $29.817 million a year ago. Adjusted income was $24.553 million, or $0.83 per fully diluted share, compared to $26.426 million, or $0.82 per fully diluted share, for the first quarter of fiscal year 2014. EBITDA (earnings before interest, taxes, depreciation and amortization) was $31.652 million against $29.135 million a year ago. Adjusted EBITDA (EBITDA excluding non-cash asset impairment charges and non-cash share-based compensation) was $41.947 million compared to $44.562 million in the same period last year. For the quarter, the company reported $9.0 million in non-cash asset impairment charges related to certain trademarks in the company's personal care segment compared to $12.049 million in non--cash asset impairment charges related to certain trademarks in the company's personal care segment. The company provided earnings guidance for the nine months and fiscal year ending February 28, 2015. For the nine months period, the company expects diluted EPS in the range of $3.47 to $3.57. Previous adjusted diluted EPS (non-GAAP) expected to be in the range of $3.47 to $3.57 compared with revised adjusted diluted EPS (non-GAAP) guidance of $4.11 to $4.21. For the fiscal year 2015, the company continues to expect net sales revenue in the range of $1.325 billion to $1.375 billion, and diluted EPS in the range of $4.02 to $4.12, which includes the non-cash asset impairment charges of $0.28 per share recorded in the first quarter of fiscal year 2015. Consistent with the company's previous outlook, adjusted diluted EPS is expected to be in the range of $4.30 to $4.40, which excludes non-cash asset impairment charges and the impact of the healthy directions acquisition. On-going fiscal year 2015 results and outlook relating to adjusted diluted EPS will exclude non-cash asset impairment charges, intangible asset amortization expense, non-cash share-based compensation expense and the impact of the healthy directions acquisition, which the company expects to be in the range of $5.15 to $5.25 for the full fiscal year 2015.

Helen of Troy Limited to Report Q1, 2015 Results on Jul 09, 2014

Helen of Troy Limited announced that they will report Q1, 2015 results at 5:00 PM, Eastern Standard Time on Jul 09, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HELE:US $52.53 USD +0.50

HELE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Elizabeth Arden Inc $16.85 USD +0.01
Inter Parfums Inc $27.40 USD +0.05
Prestige Brands Holdings Inc $32.19 USD +0.19
Revlon Inc $30.90 USD -0.14
USANA Health Sciences Inc $74.41 USD +0.11
View Industry Companies
 

Industry Analysis

HELE

Industry Average

Valuation HELE Industry Range
Price/Earnings 18.7x
Price/Sales 1.1x
Price/Book 1.9x
Price/Cash Flow 16.7x
TEV/Sales 0.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HELEN OF TROY LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.